Back to Jefferies Financial Group Inc. Jefferies Financial Group Inc.

MLTX

Showing 7 of 14 quarters

Position history for Jefferies Financial Group Inc.Jefferies Financial Group Inc.'s holdings in MoonLake Immunotherapeutics

No. Jefferies Financial Group exited its MLTX (MoonLake Immunotherapeutics) position in Q2 2026. Its Q1 2026 13F listed 500,000 shares worth $9.3M. Jefferies Financial Group first reported MLTX in Q4 2022 and held it in 11 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$338,438

Total Shares Change

-6,250

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$19.47
0
2026-Q1
Unchanged
500,000
0.0%
$9.3M0.1%$18.64
0
2025-Q4
Increased
500,000
+1900.0%
$6.6M0.0%$13.18
44
2025-Q3
Increased
25,000
+381.8%
$179,2500.0%$7.17
37
2025-Q2
Decreased
5,189
-48.1%
$244,9210.0%$47.20
0
2025-Q1
Increased
10,000
+60.0%
$390,7000.0%$39.07
34
2024-Q4
New
6,250
-
$338,4380.0%$54.15
33

Other major holders of MLTX: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used